metoclopramide has been researched along with Triple Negative Breast Neoplasms in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoclopramide is a good and cost-effective therapeutic option for chemotherapy-induced nausea and vomiting." | 1.62 | The anti-cancer effect of metoclopramide on triple-negative breast cancer cells. ( Chen, Y; Fan, R; Ji, X; Ji, Y; Liu, Y; Lu, P; Qin, S; Zhang, M; Zhao, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Zhang, M | 1 |
| Ji, X | 1 |
| Zhao, J | 1 |
| Qin, S | 1 |
| Ji, Y | 1 |
| Fan, R | 1 |
| Liu, Y | 1 |
| Lu, P | 1 |
1 other study available for metoclopramide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
The anti-cancer effect of metoclopramide on triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dopamine D2 Receptor Antagon | 2021 |